miR-106b |
7q22.1 |
4.6 |
0.0433 |
Up in prostate cancer |
Suppresses E2F1 and p21 |
miR-30b |
8q24 |
−9.2 |
0.005 |
Down in cancer stem cells |
Self renewal and survival of cancer stem cells |
miR-30c |
1p34 |
−5.6 |
1.16E−05 |
Down in cancer stem cells |
Self renewal and survival of cancer stem cells |
miR-146b |
10q24.32 |
9.3 |
1.96E−05 |
Up in thyroid, breast, pancreatic cancer |
Suppresses KIT Inducible by TNF |
miR-198 |
3q13 |
3.2 |
0.003 |
Down in hepatocellular carcinoma up in prostate cancer |
Not known |
miR-181a1 |
1q31.32 |
6.2 |
0.006 |
Up in pancreatic, thyroid and colon cancer |
Target of p53 |
miR-631 |
15.q24 |
4.7 |
0.0006 |
Not known |
Not known |
miR-1 |
18q11 |
3.1 |
0.004 |
Up in prostate cancer, down-regulated in other cancers |
Suppresses E2F1 Synaptic signaling |
miR-613 |
12p13 |
3.4 |
0.004 |
Not known |
Not known |
miR-129-1 |
7q32.1 |
5.3 |
0.039 |
Up in retinoblastoma, down-regulated in other cancers |
Not known |
miR-216 |
2p18.1 |
2.9 |
0.0017 |
Down-regulated in pancreatic cancer |
Not known |
miR-499 |
20q11.22 |
3.7 |
0.0062 |
Not know |
Expressed in myocytes, involved in cell senescence |
miR-564 |
3p21.31 |
9.4 |
1.84E−05 |
Not known |
Not known |